文献速递免疫规划传染病防控与疫情报告妇幼与学校卫生

赞比亚麻疹风疹血清学调查揭示育龄年轻女性风疹免疫空白

Measles and rubella serosurvey identifies rubella immunity gap in young adults of childbearing age in Zambia: The added value of nesting a serological survey within a post-campaign coverage evaluation survey.
PubMed 文献 · Vaccine · 2019-03-21

在赞比亚南部省将血清学调查嵌套于疫苗接种活动后覆盖评估调查中,采集9月龄以上家庭成员干血斑检测麻疹和风疹IgG。麻疹和风疹总体血清阳性率分别为95.5%和97.7%,风疹在16-30岁青少年和成人中血清阳性率为91.3%,低于疫苗活动合格儿童。

要点

  • 麻疹和风疹总体血清阳性率分别为95.5%和97.7%。
  • 疫苗活动合格儿童风疹血清阳性率98.4%,高于报告接种覆盖率89.8%。
  • 16-30岁人群风疹血清阳性率91.3%,存在免疫空白。

核心结论

  • 16岁以下儿童麻疹和风疹血清阳性率显著高于接种覆盖率估计,可能反映野病毒暴露和接种漏报。
  • 血清学调查揭示16-30岁女性存在风疹免疫空白,该年龄组预防先天性风疹综合征最为重要。
  • 将血清学调查嵌套于现有调查可整合资源并补充免疫规划所需信息。

研究设计与样本

  • 在赞比亚南部省将血清学调查嵌套于疫苗接种活动后覆盖评估调查中。
  • 采集参与调查家庭中9月龄及以上所有个体的指尖干血斑。
  • 采用酶免疫分析检测麻疹和风疹病毒特异性IgG。

主要发现

  • 麻疹病毒特异性IgG总体血清阳性率为95.5%(95%CI:92.8,97.2)。
  • 风疹病毒特异性IgG总体血清阳性率为97.7%(95%CI:96.0,98.7)。
  • 疫苗活动合格儿童风疹血清阳性率为98.4%(95%CI:95.9,99.4),显著高于报告的麻疹-风疹疫苗接种覆盖率89.8%(p=0.003)。
  • 16-30岁青少年和成人风疹血清阳性率为91.3%,显著低于疫苗活动合格儿童(p=0.049)。

临床怎么用

  • 在疫苗接种活动后覆盖评估中嵌套血清学调查,可补充接种覆盖率未能反映的免疫状态信息。
  • 关注育龄女性风疹免疫空白,评估其先天性风疹综合征风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Serological surveys can potentially complement vaccine coverage surveys, such as post-vaccination campaign coverage evaluation surveys (PCES), by providing direct information on population immunity within and outside the target age range of the mass vaccination campaign. We estimate age-specific population immunity to measles and rubella viruses in Southern Province, Zambia, and assess the value of adding serological data to vaccination coverage estimates by nesting a serological survey within a PCES. METHODS: Dried blood spots (DBS) from fingerprick blood were collected from all individuals ages nine months or older in households participating in the PCES and tested for measles and rubella virus-specific immunoglobulin G (IgG) by enzyme immunoassay (Siemens Enzygnost, Marburg, Germany). RESULTS: Overall seroprevalence was 95.5% (95% CI: 92.8, 97.2) for measles virus-specific IgG and 97.7% (95% CI: 96.0, 98.7) for rubella virus-specific IgG. Rubella seroprevalence was 98.4% (95% CI: 95.9, 99.4) among children eligible for the MR vaccination campaign, significantly higher than the reported measles-rubella (MR) vaccination campaign coverage of 89.8% (p = 0.003), and higher than the 91.3% rubella seroprevalence for adolescents and adults 16-30 years of age (p = 0.049). CONCLUSION: Seroprevalence to measles and rubella viruses in children younger than 16 years of age was significantly higher than expected from vaccination coverage estimates, likely reflecting exposure to wild-type viruses and underreporting of vaccination. The serosurvey revealed rubella immunity gaps among women 16-30 years of age, precisely the age group in which protection from rubella is most important to prevent congenital rubella syndrome. Nesting serological surveys within existing surveys can leverage resources and infrastructure while providing complementary information important to immunization programs.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Hayford K, Mutembo S, Carcelen A, et al. Measles and rubella serosurvey identifies rubella immunity gap in young adults of childbearing age in Zambia: The added value of nesting a serological survey within a post-campaign coverage evaluation survey. Vaccine. 2019. PMID: 30905529. doi:10.1016/j.vaccine.2019.02.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。